Diabetes Mellitus, Type 2: all 9,589 studies
Page 94 of 96. Open to participants first (1,332), then studies with results posted, then the rest; newest registration first within each.
- Fatty Acid Binding Protein 2 (FABP2) Ancillary ProposalCompletedNCT00256633
- Non-traditional Cardiovascular Risk Factors and Atherosclerosis in Type 2 DiabetesCompletedNCT00256607
- The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy MenCompletedNCT00256256Not applicable
- G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)TerminatedNCT00255645
- GALLANT 4 Tesaglitazar vs. GlibenclamideTerminatedNCT00255541Phase 3
- The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy FemalesCompletedNCT00254800Phase 1
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes MellitusCompletedNCT00254254Phase 2
- Use of a Portion Control Food Tool to Induce Weight Loss in Obese Type 2 Diabetics.CompletedNCT00254124Not applicable
- Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.Status unknownNCT00254085Phase 4
- Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic NephropathyCompletedNCT00253786Not applicable
- GALLEX 1 - Long Term Extension Study in Patients With Type 2 DiabetesTerminatedNCT00252876Phase 3
- GALLANT 22 Tesaglitazar vs. PlaceboTerminatedNCT00252837Phase 3
- GALLANT 2 Tesaglitazar vs. PlaceboTerminatedNCT00252772Phase 3
- Correlation of Plasma Endothelial Cell Activity With Cardiovascular Events in Patients With Diabetes Mellitus Type 2CompletedNCT00252525
- GALLANT 8 Tesaglitazar Add-on to MetforminTerminatedNCT00251953Phase 3
- GALLANT 7 Tesaglitazar Add-on to SulphonylureaTerminatedNCT00251940Phase 3
- Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.CompletedNCT00251680Phase 3
- (Mol-SHARE) Molecular Study of Health Assessment and Risk in Ethnic GroupsStatus unknownNCT00249314
- A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic ControlCompletedNCT00246987Phase 3
- US Inhaled Insulin Dose Titration StudyCompletedNCT00246623Phase 3
- Efficacy of Topiramate for Weight Loss in Subjects With Metabolic SyndromeSuspendedNCT00243984Phase 3
- GALLANT 9 Tesaglitazar vs. Placebo in Combination With InsulinTerminatedNCT00242372Phase 3
- AVANDAMET Versus Metformin For Type 2 Diabetes MellitusCompletedNCT00241605Phase 4
- Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 DiabetesCompletedNCT00241423Phase 2
- Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes MellitusCompletedNCT00241085Phase 4
- Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 DiabetesCompletedNCT00240422Phase 4
- A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 DiabetesCompletedNCT00240253Phase 4
- GIP: Glucose-dependent Insulinotropic PeptideCompletedNCT00239707Phase 1
- SMOOTH - Blood Pressure Control in Diabetic/Obese PatientsCompletedNCT00239538Phase 4
- A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1CompletedNCT00239187Phase 1
- A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00238498Phase 2
- A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin ExcretionCompletedNCT00238472Phase 4
- Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic NephropathyCompletedNCT00237952Not applicable
- Effect of Cinnamon on Glucose and Lipid Levels in Non-Insulin Dependent Type 2 Diabetes MellitusCompletedNCT00237640Phase 2
- The ADDITION Study. Intensive Treatment in People With Screen Detected Diabetes in Primary Care.CompletedNCT00237549Not applicable
- Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00237237Phase 3
- A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 DiabetesCompletedNCT00236626Phase 2
- DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European GuidelinesCompletedNCT00233649
- Lifestyle Modification Program to Reduce Risk of Coronary Heart Disease in Latina Women With DiabetesCompletedNCT00233259Not applicable
- Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes MellitusWithdrawnNCT00232362Phase 1
- Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily InsulinCompletedNCT00231725Phase 3
- A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral PolyneuropathyCompletedNCT00231673Phase 2
- A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With MetforminCompletedNCT00231660Phase 3
- A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or MetforminCompletedNCT00231647Phase 2
- A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea TherapyTerminatedNCT00231634Phase 3
- A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled DietCompletedNCT00231530Phase 3
- Rosiglitazone And Plaque Study for Type 2 Diabetes MellitusCompletedNCT00231387Phase 3
- Acute Metabolic Effects of LAF 237 in Type 2 DiabeticsCompletedNCT00230464Phase 3
- GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 DiabetesTerminatedNCT00229710Phase 3
- ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)TerminatedNCT00229684Phase 2
- Vascular Reactivity in Kidney Disease PatientsCompletedNCT00226902Not applicable
- GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes MellitusTerminatedNCT00226330Phase 3
- Feasibility Study of Digital Photography and Group Discussion for People With DiabetesTerminatedNCT00225888Not applicable
- Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With AnginaWithdrawnNCT00225342Phase 4
- Rosiglitazone-Induced Weight GainTerminatedNCT00225225Not applicable
- Canadian Trial of Dietary Carbohydrates in DiabetesCompletedNCT00223574Not applicable
- Enhancing Adherence in Type 2 Diabetes: The ENHANCE StudyCompletedNCT00222846Not applicable
- Alberta Diabetes and Physical Activity TrialCompletedNCT00221234Phase 2
- Determining the Effect on Patients of Internet-Based Diabetes Disease ManagementCompletedNCT00220207Not applicable
- Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes MellitusCompletedNCT00217061Phase 3
- GALLANT 5 Tesaglitazar Versus MetforminTerminatedNCT00214591Phase 3
- GALLANT 6 Tesaglitazar vs. PioglitazoneTerminatedNCT00214565Phase 3
- Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With InsulinCompletedNCT00213122Phase 3
- Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin TreatmentCompletedNCT00213070Phase 3
- A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes MellitusCompletedNCT00212641Phase 2
- Exercise Training in Type 2 Diabetes and HypertensionCompletedNCT00212303Phase 4
- Insulin Resistance and Central Nervous System (CNS) Function in Type 2 DiabetesCompletedNCT00212290Phase 4
- Ontario Printed Educational Materials (PEMs) for Physician Behaviour ChangeStatus unknownNCT00210275Not applicable
- A Study to Examine Changes in GIP Plasma Levels Following Gastric Bypass Surgery in Obese PatientsTerminatedNCT00207389
- Use of MCT Oil for Enhancement of Weight Loss and Glycemic Control in Obese Diabetic PatientsCompletedNCT00207233Phase 1/2
- Janssen - Glucose Regulation/Risp/OlanzCompletedNCT00205738Not applicable
- Pfizer/IVGTT/Ziprasidone/OlanzapineCompletedNCT00205725Not applicable
- Change of Lifestyle by Persons in Risk of Type 2 DiabetesStatus unknownNCT00202748Phase 3
- Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 DiabetesCompletedNCT00202033Phase 4
- Problem Solving and Cardiovascular Disease Risk Management in Diabetic BlacksCompletedNCT00201110Not applicable
- Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 DiabetesCompletedNCT00200018Not applicable
- Type 2 Diabetes Controlled Eating ExperimentCompletedNCT00198926Not applicable
- Long Term Free Living Study With Modified Foods and Type 2 DiabeticsCompletedNCT00198913Not applicable
- Diabetes Knowledge AssessmentCompletedNCT00198900
- Efficacy of 2 Diet Plans Designed for People With Type II Diabetes on Weight and Health MeasuresCompletedNCT00198757Not applicable
- Study In People With Type 2 DiabetesCompletedNCT00196989Phase 2
- Diabetes Aerobic and Resistance Exercise (DARE) StudyCompletedNCT00195884Not applicable
- Cyber Disease Management: Using the World Wide Web to Share the Medical Record With Patients at HomeCompletedNCT00194506Not applicable
- Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive DrugsStatus unknownNCT00192803Phase 4
- Local Registration Trial in China Humalog Mix 50CompletedNCT00191581Phase 3
- Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 DiabetesCompletedNCT00191464Phase 4
- Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 DiabetesCompletedNCT00191178Phase 4
- Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic PatientsCompletedNCT00189774Phase 2/3
- Internet Diabetes Self-Management WorkshopCompletedNCT00185601Not applicable
- Olmesartan Medoxomil in Diabetes MellitusCompletedNCT00185159Phase 3
- Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.CompletedNCT00184626Phase 4
- Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 DiabetesCompletedNCT00184613Phase 1
- Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 DiabetesCompletedNCT00184574Phase 3
- Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 DiabetesCompletedNCT00184561Phase 4
- Diabetes IN-CHARGE: Trial of Diabetes Intervention in the Community to Help Achieve Reduced Glucose ElevationStatus unknownNCT00182026Not applicable
- Improving Diabetes Outcomes With Activity, Nutrition and MedicationCompletedNCT00179374Not applicable
- Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube FeedingsCompletedNCT00177398Phase 4
- Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic PatientsCompletedNCT00174824Phase 4
- Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 DiabetesCompletedNCT00174681Phase 4
- Insulin Glulisine in Diabetes Mellitus, Type 2CompletedNCT00174668Phase 3